Mannitol

Mannitol

SCHEMBL22804492

CC(O)C(=O)O.OCC(O)C(O)C(O)C(O)CO

nearest known ligand 0.65

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

CHRM1DRD2DRD3DRD4HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HTR2APDE3ASIGMAR1

The experimentally established mechanism targets of Mannitol. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
PDE4A P27815 1/20 0.65
USP2 O75604 1/20 0.60
SLCO1B1 Q9Y6L6 1/20 0.60
LMNA P02545 2/20 0.58
TP53 P04637 1/20 0.58
L3MBTL1 Q9Y468 1/20 0.58
TDP1 Q9NUW8 2/20 0.55
KDM4E B2RXH2 2/20 0.46
OR51E2 Q9H255 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Mannitol SCHEMBL5794749 0.95 PDE4A (0.60) PDE4AUSP2SLCO1B1LMNATP53
Adonitol SCHEMBL27759312 0.95 PDE4A (0.58) PDE4AUSP2SLCO1B1LMNATP53
Sorbitol SCHEMBL8840893 0.93 PDE4A (0.58) PDE4AUSP2SLCO1B1LMNATP53
Xylitol SCHEMBL6859096 0.92 PDE4A (0.56) PDE4AUSP2SLCO1B1LMNATP53
Sorbitol SCHEMBL8158205 0.91 PDE4A (0.56) PDE4AUSP2SLCO1B1LMNATP53
Gluconic Acid SCHEMBL27466658 0.91 PDE4A (0.83) PDE4AUSP2SLCO1B1LMNATP53
Gluconic Acid SCHEMBL872998 0.91 PDE4A (0.83) PDE4AUSP2SLCO1B1LMNATP53
Gluconic Acid SCHEMBL30528009 0.91 PDE4A (0.83) PDE4AUSP2SLCO1B1LMNATP53
E968 SCHEMBL28446897 0.89 TP53 (0.65) PDE4AUSP2SLCO1B1LMNATP53
Gluconic Acid SCHEMBL5095328 0.89 PDE4A (0.79) PDE4AUSP2SLCO1B1LMNATP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117462509-A Enteric soft gelatin capsule R·P·谢勒技术有限公司 2024-01-30 CN disclosed
CN-112105334-B Enteric soft gelatin capsule R.P.谢勒技术有限公司 2023-09-26 CN disclosed
CN-114983936-A Octreotide acetate injection with good stability as well as preparation method and application thereof 本溪恒康制药有限公司 2022-09-02 CN disclosed
CN-114845569-A Delayed release softgel capsules in higher PH environments R.P.谢勒技术有限公司 2022-08-02 CN disclosed
EP-3986160-A1 EUTECTIC EXTRACTION OF SOLIDS Givaudan SA (CH) 2022-04-27 EP disclosed
WO-2020254579-A1 EUTECTIC EXTRACTION OF SOLIDS GIVAUDAN SA (CH) 2020-12-24 WO disclosed
CN-112105334-A Enteric soft gelatin capsule R.P.谢勒技术有限公司 2020-12-18 CN disclosed
CN-111867399-A Enteric soft gelatin capsule R.P.谢勒技术有限公司 2020-10-30 CN disclosed
CN-110960551-A Novel electrolyte sorbitol chiral resuscitation medicine composition 刘力 2020-04-07 CN disclosed
CN-110934888-A Novel electrolytic glycoside therapeutic pharmaceutical composition 刘力 2020-03-31 CN disclosed
CN-102327617-B Sulfoalkyl ether-cyclodextrin (SAE-CD) composition and preparation method thereof CYDEX PHARMACEUTICALS INC 2014-08-20 CN disclosed
CN-103221525-A Hard surface cleaners comprising low VOC, low odor alkanolamines DOW GLOBAL TECHNOLOGIES INC 2013-07-24 CN disclosed
CN-102327617-A Sulfoalkyl ether cyclodextrin compositions and its preparation method CYDEX INC 2012-01-25 CN disclosed
CN-102264888-A Polymeric aluminum compositions 2011-11-30 CN disclosed
CN-101365459-B Sulfoalkyl ether cyclodextrin compositions and methods for making same CYDEX PHARMACEUTICALS, INC. (US) 2011-11-30 CN disclosed
CN-101365459-A Sulfoalkyl ether cyclodextrin compositions and methods for making same CYDEX INC (US) 2009-02-11 CN disclosed